Skip to main content
Ipsen logo

Ipsen — Investor Relations & Filings

Ticker · IPN ISIN · FR0010259150 LEI · 549300M6SGDPB4Z94P11 PA Manufacturing
Open in API
Filings indexed 1,386 across all filing types
Latest filing 2026-05-18 Declaration of Voting R…
Country FR France
Listing PA IPN

About Ipsen

https://www.ipsen.com/

Ipsen is a global biopharmaceutical company focused on innovation and specialty care. The company develops and commercializes transformative medicines to address high unmet medical needs in three key therapeutic areas: oncology, rare diseases, and neuroscience. By leveraging its specialized expertise and strategic partnerships, Ipsen aims to accelerate the development of new therapies and improve health outcomes for patients worldwide. Its strategy is centered on advancing science with purpose to bring innovative treatments from research and development to the market.

Recent filings

Filing Released Lang Actions
Ipsen - Avril 2026 - Information mensuelle relative au nombre total des droits de vote et d’actions composant le capital social
Declaration of Voting Results & Voting Rights Announcements
2026-05-18 French
Ipsen - April 2026- Monthly information relative to the total number of voting rights and shares composing the share capital
Declaration of Voting Results & Voting Rights Announcements
2026-05-18 English
Ipsen lance un nouveau programme de rachat d’actions
Transaction in Own Shares Classification · 92% confidence The document is a regulated press release in French announcing that Ipsen has launched a new share repurchase programme (mandating a provider to buy back up to 350,000 shares over six months). It details the number of shares, percentage of capital, period, and purpose of the buyback. This corresponds exactly to a Transaction in Own Shares (share repurchase) under our taxonomy. It is not an investor presentation, dividend notice, or management change, but a share buyback announcement.
2026-05-18 French
Ipsen initiates a new share buy-back program
Transaction in Own Shares Classification · 90% confidence The document is a press release announcing Ipsen’s new share buy-back program, detailing the number of shares to be repurchased, timeframe, and purpose. This clearly falls under a transaction in the company's own shares. Therefore, it should be classified as a share repurchase/issuance notice (POS).
2026-05-18 English
Ipsen S.A. – Evolution de la composition du Conseil d’administration
Board/Management Information Classification · 88% confidence The document is a press release titled “Evolution de la composition du Conseil d'administration,” announcing the resignation of a board member and interim appointments to the Audit and Remuneration Committees. It clearly relates to changes in the company’s board of directors. This aligns with the definition of Board/Management Information (MANG).
2026-05-13 French
Ipsen S.A. – Evolution of the composition of the Board of Directors
Board/Management Information Classification · 91% confidence The document is a press release announcing the resignation of a board member and interim appointments to board committees. There is no financial data or detailed report; it is an announcement of board composition changes. This fits the definition of Board/Management Information (Code: MANG).
2026-05-13 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.